↓ Skip to main content

CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs

Overview of attention for article published in The Journal of Headache and Pain, October 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

news
2 news outlets
twitter
11 X users

Citations

dimensions_citation
66 Dimensions

Readers on

mendeley
73 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs
Published in
The Journal of Headache and Pain, October 2021
DOI 10.1186/s10194-021-01335-2
Pubmed ID
Authors

Fenne Vandervorst, Laura Van Deun, Annelies Van Dycke, Koen Paemeleire, Uwe Reuter, Jean Schoenen, Jan Versijpt

X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 73 100%

Demographic breakdown

Readers by professional status Count As %
Other 11 15%
Student > Postgraduate 8 11%
Researcher 7 10%
Student > Bachelor 5 7%
Student > Master 5 7%
Other 6 8%
Unknown 31 42%
Readers by discipline Count As %
Medicine and Dentistry 16 22%
Neuroscience 11 15%
Pharmacology, Toxicology and Pharmaceutical Science 4 5%
Nursing and Health Professions 2 3%
Agricultural and Biological Sciences 2 3%
Other 4 5%
Unknown 34 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 December 2022.
All research outputs
#1,579,993
of 25,282,542 outputs
Outputs from The Journal of Headache and Pain
#194
of 1,519 outputs
Outputs of similar age
#35,797
of 435,262 outputs
Outputs of similar age from The Journal of Headache and Pain
#9
of 29 outputs
Altmetric has tracked 25,282,542 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,519 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.6. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,262 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 29 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.